CHE
CHEMED CORP · Healthcare · Market cap $6.8B
Insiders sold $3.6M net in the last 90 days ·5 sellers, 0 buyers· latest Form 4 filed Aug 24, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8.1M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Aug 24, 2026
LEE SPENCER S
CHEMED CORP (CHE) has 29 SEC Form 4 filings (39 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Aug 24, 2026.
Inside the rolling window, 5 insiders at CHEMED CORP reported no open-market purchases and 12 open-market sales totaling $8.1M. The most active filer is president and CEO MCNAMARA KEVIN J with 7 filings. Insiders have net sold $5.9M over the trailing 6 months. The most recent open-market filing is a sale of 1,000 shares by executive vice president LEE SPENCER S, dated Aug 21, 2026, worth $541K.
- Industry:Medical - Care Facilities
- CEO:Kevin J. McNamara
- Employees:15,811
- HQ:Cincinnati, OH, US
- IPO:1973-05-03
| Source | |||||||
|---|---|---|---|---|---|---|---|
LEE SPENCER SFirst filing | executive vice president | Sale | 1,000 | $541K | Aug 24 | -6.5% | SEC ↗ |
| president and CEO | Sale | 2,000 | $1.1M | Aug 24 | -6.5% | SEC ↗ | |
MCNAMARA KEVIN JFirst in 3 months | president and CEO | Sale | 2,000 | $1.1M | Aug 4 | -6.3% | SEC ↗ |
| Director | Sale | 190 | $101K | Aug 3 | -6.4% | SEC ↗ | |
LINDELL ANDREA RFirst filing | Director | Sale | 1,347 | $603K | Jun 10 | +16.5% | SEC ↗ |
WALSH GEORGE J IIIFirst filing | Director | Sale | 500 | $219K | May 29 | +18.7% | SEC ↗ |
GRACE PATRICK PFirst filing | Director | Sale | 60 | $26K | May 8 | +19.3% | SEC ↗ |
| president and CEO | Sale | 2,000 | $842K | May 4 | +18.8% | SEC ↗ | |
| president and CEO | Sale | 1,500 | $554K | Mar 30 | +35.3% | SEC ↗ | |
MCNAMARA KEVIN JFirst in 4 months | president and CEO | Sale | 2,000 | $806K | Mar 13 | +25.9% | SEC ↗ |
| president and CEO | Sale | 2,000 | $875K | Nov 25 | — | SEC ↗ | |
MCNAMARA KEVIN JFirst filing | president and CEO | Sale | 3,000 | $1.4M | Sep 29 | — | SEC ↗ |
Congress trading CHE 10 all-time
- RRep. Lisa C. McClainPurchase$1,001 - $15,0002025-06-24
- RRep. Byron DonaldsSale$1,001 - $15,0002025-03-06
- RRep. Byron DonaldsSale$1,001 - $15,0002025-03-06
- DRep. Ro KhannaSale$1,001 - $15,0002024-02-13
- DRep. Daniel GoldmanSale$1,001 - $15,0002023-01-31
- DRep. Ro KhannaPurchase$1,001 - $15,0002023-01-11
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does CHE have?
CHEMED CORP (CHE) has 29 SEC Form 4 filings (39 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Aug 24, 2026.
When was the most recent SEC Form 4 filing for CHE?
The most recent Form 4 filing for CHE on Tracefour is dated Aug 24, 2026.
Who is the most active insider at CHE?
The most active SEC Form 4 filer at CHE in the rolling window is president and CEO MCNAMARA KEVIN J, with 7 filings.
What is the net insider flow at CHE over the last 6 months?
Over the trailing 180 days, insiders at CHE have net sold $5.9M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CHE in the current window?
Inside the rolling window, insiders at CHE bought $0 and sold $8.1M based on SEC Form 4 filings.
Can I get alerts for CHE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at CHEMED CORP (CHE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
CHEMED CORP is in the Healthcare sector.